name:-0.024544954299927
name:-0.010342836380005
name:-0.010700941085815
Gupta; Pranav Patent Filings

Gupta; Pranav

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gupta; Pranav.The latest application filed is for "systems and methods having multi-axis sensitivity and translational mode shapes".

Company Profile
8.13.22
  • Gupta; Pranav - Jaipur IN
  • Gupta; Pranav - Atlanta GA
  • Gupta; Pranav - Basking Ridge NJ
  • Gupta; Pranav - New Delhi IN
  • Gupta; Pranav - Springfield NJ
  • Gupta; Pranav - Seattle WA
  • Gupta; Pranav - Koramangala IN
  • Gupta; Pranav - Noida IN
  • Gupta; Pranav - Short Hills NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Mobility of user applications across cloud infrastructures
Grant 11,258,881 - Singh , et al. February 22, 2
2022-02-22
Systems And Methods Having Multi-axis Sensitivity And Translational Mode Shapes
App 20210385586 - Gupta; Pranav ;   et al.
2021-12-09
(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-- 1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(- methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
Grant 11,034,673 - Gupta , et al. June 15, 2
2021-06-15
Accelerometer Contact Microphones And Methods Thereof
App 20210127202 - Ayazi; Farrokh ;   et al.
2021-04-29
Mobility Of User Applications Across Cloud Infrastructures
App 20210014333 - Singh; Gaurav Kumar ;   et al.
2021-01-14
(s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-- 1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(- Methylthio)pyrrolidine-3-carboxamide Compositions For Pharmaceutical Preparations
App 20200299266 - Gupta; Pranav ;   et al.
2020-09-24
(S)-N-(3-6-isopropoxypyridin-3-3YL)-1H-indazol-5-yl)-1-(2-(4-4(1-methyl-1H- -1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H-yl)-2-oxoethyl)-3(meth- ylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
Grant 10,710,982 - Gupta , et al.
2020-07-14
(s)-n-(3-6-isopropoxypyridin-3-3yl)-1h-indazol-5-yl)-1-(2-(4-4(1-methyl-1h- -1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h-
App 20200181119 - Gupta; Pranav ;   et al.
2020-06-11
Process for preparing formulations for gastrointestinal-targeted therapies
Grant 10,617,650 - Bhambhani , et al.
2020-04-14
(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-- 1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(- methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
Grant 10,577,348 - Gupta , et al.
2020-03-03
Virtualization Agnostic Orchestration In A Virtual Computing System
App 20200034178 - Gupta; Pranav ;   et al.
2020-01-30
Sustained release formulation and tablets prepared therefrom
Grant 10,207,002 - Gupta , et al. Feb
2019-02-19
Process For Preparing Formulations For Gastrointestinal-targeted Therapies
App 20180311172 - Bhambhani; Akhilesh ;   et al.
2018-11-01
Sustained Release Formulation And Tablets Prepared Therefrom
App 20180154000 - Gupta; Pranav ;   et al.
2018-06-07
Cross-machine Build Scheduling System
App 20180150286 - Speirs; David ;   et al.
2018-05-31
(s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-- 1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(- Methylthio)pyrrolidine-3-carboxamide Compositions For Pharmaceutical Preparations
App 20170362202 - Gupta; Pranav ;   et al.
2017-12-21
Facilitating Authentication For Online Payment
App 20170357957 - Mehta; Shashank ;   et al.
2017-12-14
Automatically Identifying A Project's Staffing-availability Risk
App 20160292621 - Ciccone; Lisa ;   et al.
2016-10-06
Parenteral and oral formulations of benzimidazoles
Grant 9,259,390 - Chow , et al. February 16, 2
2016-02-16
Parenteral and oral formulations of benzimidazoles
Grant 9,259,391 - Chow , et al. February 16, 2
2016-02-16
Intravenous Formulations Of Neurokinin-1 Antagonists
App 20160024092 - Wan; Jiansheng ;   et al.
2016-01-28
Gastro-retentive Formulations
App 20160000721 - Gupta; Pranav ;   et al.
2016-01-07
Intravenous formulations of neurokinin-1 antagonists
Grant 9,101,615 - Wan , et al. August 11, 2
2015-08-11
Optimizing Facility Utilization For Service Delivery
App 20120072257 - Basak; Jayanta ;   et al.
2012-03-22
Corticosteroid Compositions And Methods Of Treatments Thereof
App 20120022032 - Wan; Jiansheng ;   et al.
2012-01-26
Intravenous Formulations Of Neurokinin-1 Antagonists
App 20110038925 - WAN; Jiansheng ;   et al.
2011-02-17
Parenteral and oral formulations of benzimidazoles
App 20100310611 - Chow; Diana Shu-Lian ;   et al.
2010-12-09
Ph Sensitive Matrix Formulation
App 20100081672 - Wan; Jiansheng ;   et al.
2010-04-01
Parenteral and oral formulations of benzimidazoles
App 20090048322 - Chow; Diana Shu-Lian ;   et al.
2009-02-19
Parenteral and oral formulations of benzimidazoles
App 20080293796 - Chow; Diana Shu-Lian ;   et al.
2008-11-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed